Biocon Biologics' Yesafili® (aflibercept) Now Publicly Funded in Ontario, Canada for the Advanced Treatment of Patients with Retinal Diseases [Yahoo! Finance]
S&P Global Inc. (SPGI)
Last s&p global inc. earnings: 4/28 07:10 am
Check Earnings Report
US:NYSE Investor Relations:
stocktwits.com/symbol/s
Company Research
Source: Yahoo! Finance
global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), is pleased to announce that Yesafili® (aflibercept), a biosimilar to Eylea® (aflibercept) injection, in vial and prefilled syringe presentations, 2 mg/0.05 mL is now publicly funded on the Ontario Drug Benefit Formulary/Comparative Drug Index for the advanced treatment of patients with retinal diseases in Canada. YESAFILI was the first biosimilar to EYLEA to be approved by Health Canada. Biocon Biologics (PRNewsfoto/Biocon Biologics) The Ontario Drug Benefit (ODB) Formulary is the official listing that determines which prescription medicines are covered under the public insurance system in Ontario, Canada's largest province. This listing, which was effective August 29, 2025, ensures eligible patients will be covered through public funding, improving access to care. YESAFILI (aflibercept) is approved for treating neovascular (wet) age-related macular degeneration (AMD), visual impairment due
Show less
Read more
Impact Snapshot
Event Time:
SPGI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SPGI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SPGI alerts
High impacting S&P Global Inc. news events
Weekly update
A roundup of the hottest topics
SPGI
News
- American Pacific Announces Share Payments to Three Former Employees [Yahoo! Finance]Yahoo! Finance
- Green Bond Issuance Hits $947 Billion as AI Lifts Energy Demand [Yahoo! Finance]Yahoo! Finance
- S&P Global: Intelligence Player Intelligent Here? [Seeking Alpha]Seeking Alpha
- Popular analyst sets bold 2026 price target on Nvidia stock [Yahoo! Finance]Yahoo! Finance
- Saks Global ‘Exploring All Potential Paths' On Anniversary of Neiman Marcus Deal [Yahoo! Finance]Yahoo! Finance
SPGI
Earnings
- 10/31/25 - Beat
SPGI
Sec Filings
- 12/16/25 - Form 8-K
- 12/4/25 - Form 8-K
- 12/1/25 - Form 8-K
- SPGI's page on the SEC website